反応 #70427

ord-09601bab574c4bba8afd367d1b7dbbbe

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    抽出extracted with chloroform
  2. 2
    洗浄The organic layer was washed with brine
  3. 3
    乾燥dried over anhydrous sodium sulfate
  4. 4
    濃縮concentrated under reduced pressure
  5. 5
    その他The residue was purified by silica gel column chromatography (chloroform/methanol=100/1)

実験手順

A solution of tert-butyl 4-[2-(4-carboxy-3-fluorophenoxymethyl)pyridin-5-yl]piperidine-1-carboxylate (Example 10) (21 mg, 0.049 mmol), 1-hydroxybenzotriazole monohydrate (9.3 mg, 0.061 mmol) and 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride (12 mg, 0.061 mmol) in dry tetrahydrofuran (0.5 mL) was stirred at room temperature for 1 hour followed by the addition of a solution of (S)-(−)-2-amino-1-propanol (7.6 μL, 0.098 mmol) in dry tetrahydrofuran (0.05 mL). The mixture was stirred at room temperature overnight, to which was added saturated aqueous sodium hydrogen carbonate solution and extracted with chloroform. The organic layer was washed with brine, dried over anhydrous sodium sulfate and concentrated under reduced pressure. The residue was purified by silica gel column chromatography (chloroform/methanol=100/1) to give the title compound as a white crystal (21 mg, yield 86%).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US08536176B2uspto-grants-2013_09